The move allows Mars’ Science & Diagnostics division to expand its European footprint.
Munich-based provider of laboratory diagnostic services SYNLAB has agreed to sell its veterinary business to Mars.
SYNLAB Vet will join the portfolio of Mars Petcare, integrating their services across veterinary health and diagnostics, nutrition, innovation, and technology.
Nefertiti Greene, President at Mars Science & Diagnostics, says that the transaction complements their existing diagnostics business and believes it will bring additional reach across the European region.
SYNLAB, which did not reveal the value of the deal, has allegedly decided to sell the business to Mars to refocus on its core human diagnostic operations.
According to some sources, the firm’s veterinary diagnostics unit generated only 1% of the group’s total €3.2 billion ($3.4B) revenue in 2022.
SYNLAB operates across 40 countries over 4 continents, primarily boasting a strong network in Europe.
The latest articles
Industry responds to the need for voluntary copper claims in pet food
AAFCO sought opinion after the pet industry largely opposed any change in the current rules due to a lack of scientific evidence.
Pet Food
15 May 2024
Analysis: The state of the pet hospitality sector
From investments to mergers and acquisitions, the field is generating interest within the industry.
Trends & Insights
15 May 2024
VAFO acquires remaining stake in German pet food maker Allco Tiernahrung
The Czech group announced the acquired company will become Vafo.de by the end of 2024.
News
14 May 2024
GET THE NEWSLETTER
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.